Leukemia & Lymphoma Society - Chicago, Illinois 60661

Leukemia & Lymphoma Society is categorized under Organizations in Chicago, IL .

Business Name: Leukemia & Lymphoma Society
Contact Person: Nancy Mcinroy, Executive Director
Address: 651 West Washington Boulevard # 400, Chicago, Illinois 60661
Phone Number: (312) 651-7350
Website Address: lls.org
Annual Revenue (USD): $5.000.000 to $9.999.999
Location Type: Branch
Employee Number: 1 to 4
Business Type: B2B & B2C
Business Category: Organizations
SIC Code: 8699
NAICS Code: 6219993
Share This Business:
Related Businesses: John C Kulis Charitable Foundation - Chicago, IL 60661
Bleeding Disorders-Alliance - Chicago, IL 60661
Howard Shapiro Foundation - Chicago, IL 60661
Enivar Charitable Fund - Chicago, IL 60661
Tengelsen Family Foundation - Chicago, IL 60661
Marian L Freeman Foundation - Chicago, IL 60661
United State Gypsum Foundation Inc - Chicago, IL 60661
William Zimmerman Foundation - Chicago, IL 60661
The Sunshine Foundation - Chicago, IL 60661
Alvin H Baum Family Fund - Chicago, IL 60661
D & R Fund - Chicago, IL 60661
Gies Foundation - Chicago, IL 60661
Global Alliance For Africa Inc - Chicago, IL 60661
Coleman Foundation - Chicago, IL 60661
Horwitz Charitable Fund - Chicago, IL 60661

The company Leukemia & Lymphoma Society provides BOTH services in the form of Organizations from its branch in Illinois. 1 to 4 employees work for Leukemia & Lymphoma Society, and the business now earns $5.000.000 to $9.999.999 per annum.

Leukemia & Lymphoma Society was launched in 0 and is classified under SIC code and category 8699 , and NAICS number and grouping 6219993 . To contact Leukemia & Lymphoma Society, please call Nancy Mcinroy, Executive Director with the phone number (312) 651-7350 or visit its branch at 651 West Washington Boulevard # 400 in Chicago, Illinois 60661.

The location of the branch can also be found using the coordinates 41.88315,-87.64422. Read more details about this business on the webpage lls.org or follow the company’s social media accounts, on Twitter and on Facebook.